Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:00 PM
Ignite Modification Date:
2025-12-24 @ 4:00 PM
NCT ID:
NCT03300466
Brief Summary:
This is a study to assess the performance and safety of GP0045 when injected in the nasolabial folds.
There is an 18 months follow up period.
Study:
NCT03300466
Study Brief:
Protocol Section:
NCT03300466